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Abstract
First-degree relatives of patients diagnosed with schizophrenia (SZ-FDRs) show simi-
lar patterns of brain abnormalities and cognitive alterations to patients, albeit with
smaller effect sizes. First-degree relatives of patients diagnosed with bipolar disorder
(BD-FDRs) show divergent patterns; on average, intracranial volume is larger com-
pared to controls, and findings on cognitive alterations in BD-FDRs are inconsistent.
Here, we performed a meta-analysis of global and regional brain measures (cortical
and subcortical), current IQ, and educational attainment in 5,795 individuals (1,103
SZ-FDRs, 867 BD-FDRs, 2,190 controls, 942 schizophrenia patients, 693 bipolar
patients) from 36 schizophrenia and/or bipolar disorder family cohorts, with
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standardized methods. Compared to controls, SZ-FDRs showed a pattern of wide-
spread thinner cortex, while BD-FDRs had widespread larger cortical surface area. IQ
was lower in SZ-FDRs (d = −0.42, p = 3 × 10−5), with weak evidence of IQ reductions
among BD-FDRs (d = −0.23, p = .045). Both relative groups had similar educational
attainment compared to controls. When adjusting for IQ or educational attainment,
the group-effects on brain measures changed, albeit modestly. Changes were in the
expected direction, with less pronounced brain abnormalities in SZ-FDRs and more
pronounced effects in BD-FDRs. To conclude, SZ-FDRs and BD-FDRs show a differ-
ential pattern of structural brain abnormalities. In contrast, both had lower IQ scores
and similar school achievements compared to controls. Given that brain differences
between SZ-FDRs and BD-FDRs remain after adjusting for IQ or educational attain-
ment, we suggest that differential brain developmental processes underlying predis-
position for schizophrenia or bipolar disorder are likely independent of general
cognitive impairment.
K E YWORD S
bipolar disorder, education, intelligence, neuroimaging, relatives, schizophrenia
1 | INTRODUCTION
Schizophrenia and bipolar disorder are highly heritable disorders with
a shared genetic architecture (Anttila et al., 2018; Lee et al., 2013;
Lichtenstein et al., 2009). Both patient groups are characterized by
overlapping patterns of structural brain abnormalities (Arnone
et al., 2009; Ellison-Wright & Bullmore, 2010; Haijma et al., 2013;
Hibar et al., 2016; Hibar et al., 2018; Ivleva et al., 2017; McDonald
et al., 2004; Okada et al., 2016; van Erp et al., 2016, 2018). In con-
trast, our recent ENIGMA–Relatives meta-analysis showed that their
family members—who share the risk for the disorder but generally are
not confounded by medication use or other illness related factors—
show divergent patterns of global brain measures (de Zwarte,
Brouwer, Agartz, et al., 2019). That study found that first-degree
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relatives of patients diagnosed with bipolar disorder (BD-FDRs) had a
larger intracranial volume (ICV) which was not present in first-degree
relatives of patients diagnosed with schizophrenia (SZ-FDRs). When
we adjusted for ICV, no differences were found between BD-FDRs
and controls but SZ-FDRs still showed significantly smaller brain vol-
umes, diminished cortical thickness and larger ventricle volume com-
pared to controls. These findings suggest that individuals at familial
risk for either bipolar disorder or schizophrenia may show disease-
specific deviations during early brain development.
Differential neurodevelopmental trajectories in schizophrenia and
bipolar disorder have also been linked to intelligence quotient (IQ)
development and school performance (Parellada, Gomez-Vallejo,
Burdeus, & Arango, 2017). Schizophrenia has been associated with
poorer cognitive performance, as well as decreases in cognitive perfor-
mance over time, years before onset (Agnew-Blais & Seidman, 2013;
Dickson, Laurens, Cullen, & Hodgins, 2012; Hochberger et al., 2018;
Kendler, Ohlsson, Sundquist, & Sundquist, 2015; Khandaker, Barnett,
White, & Jones, 2011; Reichenberg et al., 2005; Woodberry, Giuliano, &
Seidman, 2008), while premorbid IQ or educational attainment are often
not affected or are even higher in individuals who later develop bipolar
disorder (MacCabe et al., 2010; Smith et al., 2015; Tiihonen et al., 2005;
Zammit et al., 2004).
Both IQ and educational attainment are highly heritable (Devlin,
Daniels, & Roeder, 1997; Heath et al., 1985; Tambs, Sundet, Magnus, &
Berg, 1989). Consequently, similar patterns of cognitive performance
and educational attainment are often found among relatives. Indeed,
cognitive alterations have been reported in SZ-FDRs compared to con-
trols (Hughes et al., 2005; Kremen, Faraone, Seidman, Pepple, &
Tsuang, 1998; McIntosh, Harrison, Forrester, Lawrie, & Johnstone, 2005;
Niendam et al., 2003; Sitskoorn, Aleman, Ebisch, Appels, & Kahn, 2004;
Van Haren, Van Dam, & Stellato, 2019; Vreeker et al., 2016) and in BD-
FDRs compared to controls (Vonk et al., 2012; Vreeker et al., 2016).
Vreeker et al. (2016) showed, in a direct comparison, a discrepancy
between IQ and educational attainment in SZ-FDRs and BD-FDRs: both
groups showed lower IQ but similar educational attainment compared to
controls. These findings suggest that, despite the high genetic and pheno-
typic overlap between intelligence and educational attainment in the gen-
eral population (Sniekers et al., 2017; Strenze, 2007), it is important to
differentiate between these two measures when investigating individuals
at familial risk for mental illness.
Intelligence has consistently been associated with brain structure in
the general population (McDaniel, 2005). Our recent schizophrenia fam-
ily studies reported that IQ is intertwined with most of the brain abnor-
malities in SZ-FDRs (de Zwarte, Brouwer, Tsouli, et al., 2019; van Haren
et al., 2020). Altered brain structure and cognitive deficits observed in
schizophrenia patients could be a direct consequence of the association
observed in the general population or alternatively, both could be cau-
sed by the disease through independent mechanisms. IQ and brain
structure are both considered indirect measures for (early) neuro-
development. Indeed, both brain structure and cognitive deficits in
schizophrenia relatives are apparent in children and adolescents at high
familial risk (van Haren et al., 2020), suggesting that individuals at famil-
ial risk for schizophrenia show altered neurodevelopment already early
in life. This would suggest that genetic risk for the disease influences
both cognition and the brain and we cannot study one without the
other. However, in BD-FDRs, it remains unknown how IQ and risk for
bipolar disorder interact with the brain. In particular, the relationship
between IQ and the familial predisposition for a larger ICV in BD-FDRs
is unclear. Hence, it is of interest to see how brain anomalies and intelli-
gence differences are related to each other in those at familial risk for
schizophrenia and bipolar disorder.
Here, through the Enhancing Neuro Imaging Genetics Through
Meta Analysis (ENIGMA)-Relatives Working Group, we performed
meta-analyses of magnetic resonance imaging data sets consisting of
SZ-FDRs and/or BD-FDRs, probands, and matched control participants.
There were three main aims. First, we extended our findings of group
differences in global brain measures between relatives and controls (and
patients) for both disorders (de Zwarte, Brouwer, Agartz, et al., 2019) by
adding local cortical measures. This allowed us to investigate whether
the findings were limited to specific (functional) brain regions, or can be
attributed to a more global mechanism. Previous ENIGMA meta-
analyses have shown that patients with schizophrenia have widespread
attenuation of cortical thickness and surface area (with largest effects in
frontal and temporal lobe regions), with evidence for regional specificity
only in the thickness findings (van Erp et al., 2018). In contrast, patients
with bipolar disorder have shown thinner cortex in frontal, temporal and
parietal regions, but no differences in surface area, compared to controls
(Hibar et al., 2018). Based on the patient findings and our previous
ENIGMA-Relatives findings for global brain measures—showing globally
thinner cortex in SZ-FDRs and larger surface area in BD-FDRs—we
expected to find subtle regional differences in these measures in the rel-
atives. In particular, we predicted locally thinner cortex in SZ-FDRs with
a similar pattern to previous observations in patients but with smaller
effect sizes (van Erp et al., 2018). Based on the larger ICV and global
surface area reported in our previous study, locally larger surface area in
BD-FDRs was expected in contrast to previous bipolar patient findings
(Hibar et al., 2018). Second, in cohorts that had information on current
IQ and/or educational attainment (the latter is defined as years of edu-
cation completed), we meta-analyzed the group effects of IQ and edu-
cational attainment between relatives and controls (and patients) for
both disorders. We hypothesized that both SZ-FDRs and BD-FDRs
would have, on average, lower current IQ than controls. Educational
attainment findings in relatives have been inconsistent, with findings of
both lower educational attainment and no detectable differences
between relatives and controls; therefore, we expected subtle but sig-
nificant differences between both SZ-FDRs and BD-FDRs and controls.
Third, we investigated the influence of IQ and educational attainment
on global and local brain differences between relatives and controls. We
hypothesized that IQ will account for most of the brain abnormalities
found in SZ-FDRs, while a lower IQ most likely would not explain our
previously reported larger ICV in BD-FDRs because of the well-
established positive relationship between overall head size and IQ
(McDaniel, 2005). The moderating effect of educational attainment on
brain abnormalities is expected to be less pronounced than that of IQ,
as we are only expecting modest group differences in educational
attainment between relatives and controls.
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2 | MATERIALS AND METHODS
2.1 | Study samples
This study included 5,795 participants from 36 family cohorts (age range
6–72 years). In total, 1,103 SZ-FDRs (42 monozygotic co-twins, 50 dizy-
gotic co-twins, 171 offspring, 728 siblings, 112 parents), 867 BD-FDRs
(32 monozygotic co-twins, 33 dizygotic co-twins, 453 offspring, 331 sib-
lings, 18 parents), 942 patients with schizophrenia, 693 patients with
bipolar disorder and 2,190 controls were included (Tables 1 and 2). All
family cohorts included their own control participants. Controls did not
have a family history of schizophrenia or bipolar disorder. SZ-FDRs or
BD-FDRs were defined by having a first-degree family member with
schizophrenia or bipolar disorder, respectively, and not having experi-
enced (hypo)mania and/or psychosis themselves. Demographic charac-
teristics for each cohort and their inclusion criteria are summarized in
Tables 1 and 2 and Table S1. The cohorts in the current meta-analysis
overlap largely, but not completely with those in our previous meta-
analysis (de Zwarte, Brouwer, Agartz, et al., 2019). All study centers
obtained approval from their respective ethics committee for research,
following the Declaration of Helsinki. Informed consent was obtained
from all participants and/or parents, in the case ofminors.
2.2 | Intelligence quotient
Twenty-five family cohorts had either full scale IQ scores or estimated
IQ scores available for most of their participants. In total, 4,095
participants with a measure of IQ were included; 968 SZ-FDRs,
507 BD-FDRs, 788 patients with schizophrenia, 313 patients with
bipolar disorder and 1,549 controls (Tables 1 and 2; Table S2 for IQ
test battery description).
2.3 | Educational attainment
Educational attainment was measured as years of completed educa-
tion. These data were available in 27 family cohorts. Subjects were
included if they were at least 25 years old to avoid the bias of includ-
ing participants still in school. In total, 3,056 participants were
included; 614 SZ-FDRs, 306 BD-FDRs, 616 patients with schizophre-
nia, 381 patients with bipolar disorder and 1,139 controls (Tables 1
and 2; Table S3 for educational attainment description).
2.4 | Image acquisition and processing
Structural T1-weighted brain magnetic resonance imaging scans were
acquired at each research center (Table S4). Cortical and subcortical
reconstruction and volumetric segmentations were performed with
the FreeSurfer pipeline (Table S4) (http://surfer.nmr.mgh.harvard.edu/
fswiki/recon-all/; Fischl, 2012). The segmentations were quality
checked according to the ENIGMA quality control protocol for sub-
cortical volumes, cortical thickness and surface area (http://enigma.ini.
usc.edu/protocols/imaging-protocols/). Global brain measures, regional
cortical thickness, and surface area measures and subcortical volumes
were extracted from individual images (Fischl & Dale, 2000; Fischl,
Sereno, & Dale, 1999).
F IGURE 1 Cohen's d effect sizes comparing bipolar relatives and schizophrenia relatives to controls on (a) regional cortical thickness (left) and
cortical surface area (right), (b) corrected for mean cortical thickness (left) and total surface area (right). Red lined regions survive false discovery
rate correction for multiple testing (q < 0.05)
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2.5 | Statistical meta-analyses
All statistical analyses were performed using R (http://www.rproject.
org). Linear mixed model analyses were performed within each cohort
for bipolar disorder and schizophrenia separately, comparing relatives
(per relative type) with controls and, if present, patients with controls,
while taking family relatedness into account (http://CRAN.R-project.
org/package=nlme; Pinheiro & Bates, 2000). Patients were analyzed as a
sanity check as effects in patients are not themain focus of the study; for
differences between patients and controls we refer to Supporting
F IGURE 2 Cohen's d effect
sizes comparing bipolar disorder
patients (light blue), bipolar
disorder relatives (blue),
schizophrenia patients (pink), and
schizophrenia relatives (red) to
controls for intelligence quotient
scores (IQ; top) and educational
attainment (EduYears; bottom).
The error bars depict the lower
and upper 95% confidence
intervals (CIs). *p < .001
F IGURE 3 Cohen's d effect sizes
comparing schizophrenia relatives (red),
and bipolar disorder relatives (blue) to
controls on (a) global brain measures,
corrected for (b) intracranial volume (ICV),
(c) intelligent quotient (IQ), (d) educational
attainment. Analyses displayed in (a) and
(b) have been presented in our previous
study, but are repeated here, for
completeness, albeit with slightly different
cohorts (de Zwarte, Brouwer, Agartz,
et al., 2019). Error bars depict the lower
and upper 95% confidence intervals (CIs).
*q < 0.05, corrected. GM, gray matter; NA,
not corrected for ICV; WM, white matter
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Information. Mean centered age, age squared, and sex were included as
covariates. Brain measures were corrected for lithium use at time of scan
in patients with bipolar disorder by adding a covariate (yes = 1/no = 0).
All global brain measures and subcortical volume analyses were per-
formed both with and without adjusting for ICV by including ICV as
covariate. No interaction terms were modeled. All regional cortical thick-
ness analyseswere performedwith andwithout correction for mean cor-
tical thickness and all regional cortical surface areas with and without
correction for total surface area to assess regional specificity. Analyses
of multiscanner studies included binary dummy covariates for n − 1
scanners. Cohen's d effect sizes and 95% confidence intervals were cal-
culatedwithin each cohort separately and pooled per disorder for all rela-
tives combined, and for patients as a group, using an inverse variance-
weighted random-effectsmeta-analysis. All random-effectsmodelswere
fitted using the restricted maximum likelihood method. False discovery
rate (q < 0.05) thresholding across all global and subcortical phenotypes,
and separately per regional phenotype, was used to control for multiple
comparisons for the analyses between relatives and controls, and
between patients and controls (Benjamini & Hochberg, 1995). Correla-
tions between brain measures and IQ, brain measures and educational
attainment, and between IQ and educational attainment were estimated
by performing linear mixed model analyses in the overall sample and in
the relative groups only, based on the gathered statistics of the local ana-
lyses. The resulting t-statistics were converted to correlation r with R
package “esc” (http://CRAN.R-project.org/package=esc). Analyses were
generally performed locally by the research center that contributed the
cohort, using code created within the ENIGMA-Relatives Working
Group (scripts available upon request). For some cohorts, data were sent
to themain site for analysis.
3 | RESULTS
3.1 | Cortical thickness
SZ-FDRs had a thinner cortex in most cortical regions, compared to
controls, with a thinner bilateral pars orbitalis surviving correction for
multiple testing (left d = −0.17, right d = −0.16, q < 0.05 corrected;
Figure 1a). There were no significant differences in regional cortical
thickness in BD-FDRs compared to controls.
To investigate whether findings were driven by a global effect we
corrected for mean cortical thickness. None of the findings survived
correction for multiple testing in SZ-FDRs. BD-FDRs had a signifi-
cantly thicker right caudal middle frontal cortex (d = +0.21, q < 0.05
corrected) (Figure 1b). For all regional cortical thickness effect sizes,
and for the patient findings, see Figure 1, and Figures S1 and S2.
3.2 | Cortical surface area
Differences between SZ-FDRs and controls were subtle and none
were statistically significant. BD-FDRs had larger cortical surface areas
in many cortical areas compared to controls, with a significantly larger
cortical surface area in the left transverse temporal, left para-
hippocampal, right superior temporal, right supramarginal and right
transverse temporal regions surviving correction for multiple testing
(d's > +0.15, q < 0.05 corrected) (Figure 1a).
When controlling for total surface area to investigate regional
specificity, none of the findings survived (Figure 1b). For all regional
cortical surface area effect sizes, and for the patient findings see
Figure 1, and Figures S3 and S4.
3.3 | Intelligence quotient
SZ-FDRs had significantly lower IQ compared to controls with a
medium effect size d = −0.42 (p = 3 × 10−5). BD-FDRs showed mild
IQ reductions compared to controls and of borderline significance
with effect size d = −0.23 (p = .045; Figure 2). These findings translate
to an average of 6.3 IQ points lower in SZ-FDRs and 3.5 IQ points
lower in BD-FDRs compared to controls. In SZ-FDRs, most effect
sizes of the global brain measures were slightly smaller after control-
ling for IQ; none of them survived correction for multiple testing
(Figure 3c, Table S5, Figures S5 and S6). After controlling for IQ, most
effect sizes of the global brain measures were slightly larger in BD-
FDRs; however, after correction for multiple testing only larger cau-
date volume survived (d = +0.23; q < 0.05 corrected) (Figure 3c,
Table S5, Figure S5 and S6). For all effect sizes and the effects in
patients, see Table S5–S8, and Figure S5 and S6.
3.4 | Educational attainment
Both SZ-FDRs and BD-FDRs did not differ from controls on years of
education completed (Figure 2). After adjusting for educational attain-
ment, the effect sizes in most global brain measures were slightly
smaller in SZ-FDRs (none of which survived correction for multiple
testing), while the effect sizes of the global brain measures were
slightly larger in BD-FDRs, with a significantly larger ICV (d = +0.25,
q < 0.05 corrected; Figure 3d, Table S5, Figure S5 and S6). For all
effect sizes and the effects in patients, see Tables S5–S8, and
Figure S5 and S6.
3.5 | Correlations between IQ, educational
attainment, and brain measures
The correlation between IQ and educational attainment in the total
sample was r = .40 (p = 4 × 10−22). All correlations between IQ and
global and subcortical brain measures were positive (ranging from
r = .06 and r = .22 [q < 0.05 corrected], except for the third [r = −.04]
and lateral ventricles [r = −.01]; Table S9; for the results in the SZ-
FDRs or BD-FDRs subgroups see Table S10). A significant positive
correlation was found between educational attainment and total
brain, cortical gray matter, cerebellar gray and white matter, and hip-
pocampal volume (r = .06–.08, q < 0.05 corrected; Table S9).
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4 | DISCUSSION
In previous work from the ENIGMA-Relatives Working Group we
showed that BD-FDRs had a larger ICV which was not found in SZ-
FDRs; when we adjusted for ICV, no differences in global brain mea-
sures were found between BD-FDRs and controls, while SZ-FDRs had
significantly smaller brain volumes, diminished cortical thickness, and
larger ventricle volume compared to controls (de Zwarte, Brouwer,
Agartz, et al., 2019). In this study, we extended the investigation to
compare local cortical measures, IQ and educational attainment in SZ-
FDRs and BD-FDRs with controls and investigated the effect of IQ
and educational attainment on global and local brain measures in the
relatives.
The main findings in the current study were that: (a) SZ-FDRs had
a thinner cortex in most cortical regions, compared to controls, with a
thinner bilateral pars orbitalis surviving correction for multiple testing.
However, these findings may reflect a global effect rather than region-
ally specific effect. In contrast, BD-FDRs had a significantly thicker
caudal middle frontal cortex when compared to controls that was only
present when statistically controlling for global thickness and may
thus reflect regionally specific sparing; (b) only BD-FDRs (and not SZ-
FDRs) had larger cortical surface area in the temporal lobe, which was
no longer present after statistically controlling for total surface area;
(c) IQ was lower in both BD-FDRs and SZ-FDRs, while educational
attainment did not differ between the relatives and controls; (d) there
was a modest yet significant correlation between IQ and most brain
measures in the full sample; however, statistically controlling for indi-
vidual differences in IQ and educational attainment only minimally
changed the group effects on the brain measures the expected direc-
tion, that is, effect sizes of brain measure differences between groups
decreased for SZ-FDRs and increased for BD-FDRs after adjusting for
IQ or educational attainment.
4.1 | Cortical thickness and surface area in the
relatives
SZ-FDRs had a thinner cortex in most brain areas. This pattern of find-
ings is comparable to that in the included patient sample (Figure S1)
as well as in the much larger sample of patients diagnosed with
schizophrenia in an earlier ENIGMA study (van Erp et al., 2018). How-
ever, effect sizes are lower in SZ-FDRs. The most pronounced effect
was observed in the bilateral pars orbitalis. This region has previously
been associated with language function in those at familial risk for
schizophrenia (Francis et al., 2012) and in individuals with nonclinical
auditory verbal hallucinations (Van Lutterveld et al., 2014). When sta-
tistically controlling for mean cortical thickness this finding was no
longer significant, suggesting that thinner cortex in SZ-FDRs is a
global effect. In contrast, the pattern in BD-FDRs was diffuse with
both thicker and thinner cortical regions, whereas bipolar patients
showed globally thinner cortex (Figure S1), consistent with previous
findings (Hibar et al., 2018). After correction for mean cortical
thickness the right caudal middle frontal cortex was significantly thicker
when compared to controls, suggesting regionally specific cortical
thickness abnormalities in BD-FDRs.
Regional cortical surface area findings showed, on the one hand,
that where the patients with schizophrenia had overall smaller surface
area (Figure S3; van Erp et al., 2018), the effects in SZ-FDRs were
even more subtle, and in both directions, compared to controls. On
the other hand, BD-FDRs had widespread larger regional cortical sur-
face area when compared to controls, in accord with our previous
findings of larger total surface area in BD-FDRs (de Zwarte, Brouwer,
Agartz, et al., 2019). While total surface area in patients with bipolar
disorder was not significantly larger, we did see a pattern of mostly
larger regional cortical surface area in the bipolar patients as well
(Figure S3), with most prominent findings in the temporal lobe, in
auditory regions associated with language (Crinion, Lambon-Ralph,
Warburton, Howard, & Wise, 2003; Saur et al., 2008). This finding
was not reported in the large ENIGMA bipolar disorder meta-analysis
(Hibar et al., 2018); however, findings in that study were all corrected
for ICV which most likely reduced the global surface area differences.
In line with this, when we corrected for overall surface area, regional
surface differences in BD-FDRs was no longer significant, suggesting
that the larger surface area in BD-FRDs was a global effect.
Cortical thickness and surface area are highly heritable and largely
influenced by independent genetic factors (Grasby et al., 2020; Strike
et al., 2019). The latest cortical thickness and surface area genome-
wide association study (GWAS) showed that the effects of genetic
variants associated with surface area are more likely to be prenatal,
while cortical thickness effects are more likely postnatal (Grasby
et al., 2020), supporting the radial unit hypothesis that cortical thick-
ness and surface area originate from two distinct processes in early
brain development (Rakic, 1988). That BD-FDRs and SZ-FDRs show
different patterns of abnormal cortical thickness and surface area,
strengthens the notion that genetic predisposition may underlie dis-
tinct neurodevelopmental trajectories for these disorders early in life.
4.2 | Discrepancy between IQ and educational
attainment
Given the high genetic (rg = .7 [Sniekers et al., 2017]) and phenotypic
(r = .5 [Strenze, 2007]) correlation between intelligence and educa-
tional attainment, educational attainment is often considered a proxy
for IQ. In the current study, we found a phenotypic correlation of
r = .4 between IQ and educational attainment. This implies that educa-
tional attainment is at most a weak proxy for IQ; it only explains 16%
of the variance. We showed that IQ and educational attainment act
differently in relatives, that is, lower IQ in SZ-FDRs and BD-FDRs than
in controls, with larger alterations in SZ-FDRs, but no differences in
educational attainment between SZ-FDRs and BD-FDRs as compared
to controls. These findings are in line with an earlier study—of which a
subset of the participants is included in the present study—
investigating IQ and educational attainment in SZ-FDRs and BD-FDRs
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(Vreeker et al., 2016), suggesting that even though relatives have a
lower IQ on average, gross school performance and engagement is
not necessarily affected. It has previously been shown that differenti-
ating intelligence from educational performance is important, as other
factors besides intelligence are predictive of educational performance
(Chamorro-Premuzic & Furnham, 2003; Deary, Strand, Smith, &
Fernandes, 2007). In addition, completing a level of education gives
little insight into the level of academic performance (e.g., grades). In
fact, those measures are only partly correlated (Strenze, 2007). Per-
haps, the modest cognitive alterations in the relatives cannot be
picked up by a categorical measure such as educational attainment or
the cognitive alterations must reach a certain threshold to lead to a
lower level of school performance, which may be the case in
patients with schizophrenia (who have the largest negative effect
size for IQ and are significantly different from controls in educa-
tional attainment).
4.3 | IQ, educational attainment and the brain
IQ and educational attainment both share genetic variance with ICV
(rg = .29 and rg = .34, respectively (Okbay et al., 2016; Sniekers
et al., 2017). Therefore, we speculated previously that the larger ICV
reported in BD-FDRs could potentially be confounded by higher cog-
nitive functioning (de Zwarte, Brouwer, Agartz, et al., 2019; de
Zwarte, Brouwer, Tsouli, et al., 2019). Here, we showed that in the
total sample ICV and all global brain measures were significantly cor-
related with IQ, except the ventricles, while correlations between the
brain measures and educational attainment were much smaller.
Adding to that, IQ was significantly lower in the relatives while this
was not the case for educational attainment. Based on these findings,
we propose that IQ is a more informative measure than educational
attainment to explain variation in brain measures or group differences
in brain measures.
As mentioned, only small-to-modest effects of IQ in relation to
brain abnormalities in those at familial risk were reported, but these
were in the expected direction. In SZ-FDRs, adjusting for IQ explained
part of the effect of familial risk for schizophrenia in total brain, gray
and white matter volumes (i.e., effect sizes decreased). This was pre-
viously shown in two twin studies (both included in this study;
Bohlken, Brouwer, Mandl, Kahn, & Hulshoff Pol, 2016; Toulopoulou
et al., 2015) and a study that included a subset of the present partici-
pants using a mega-analysis (de Zwarte, Brouwer, Tsouli, et al., 2019).
Interestingly, adjusting for IQ resulted in an even larger ICV difference
in BD-FDRs as compared to controls. Given that a larger ICV is associ-
ated with a higher IQ in healthy individuals, these findings suggest
that the larger ICV in BD-FDRs is unrelated to differences in IQ
(which was nonsignificantly lower in BD-FDRs compared to controls).
Future work could compare the finding of ICV in risk for bipolar disor-
der to autism, another neurodevelopmental disorder. Patients with
autism have larger ICV compared to controls (Van Rooij et al., 2018),
while not having a functional benefit in form of higher intelligence.
One could argue the same (to a much lesser extent) is true for the
BD-FDRs. This may add another piece of information to disentangle
risk for psychiatric disease, brain deficits and cognition.
Taken together, the study findings provide suggestive evidence
for different genetic influences on neurodevelopmental processes in
SZ-FDRs and BD-FDRs, leading to larger ICV and lower IQ in those at
familial risk for bipolar disorder and lower IQ and but similar ICV in
those at familial risk for schizophrenia compared to controls.
4.4 | Limitations
A few limitations to this study should be taken into account. This
work is a meta-analysis of multiple cohorts from research centers
around the world. We were therefore not able to perform analyses
such as predictive modeling which requires the raw data. One of the
main reasons to choose this approach is that the actual imaging data
does not have to be shared, which substantially increased our sample
size. The study included heterogeneous samples (e.g., in acquisition
protocols, scanner field strength, FreeSurfer version, IQ test battery,
schooling systems, inclusion and exclusion criteria). Meta-analysis
approaches find consistent effects despite this variance but cannot
account for all sources of heterogeneity. One source of heterogeneity
might also be the substantial age differences between the different
cohorts. Both adult and children/adolescent cohorts were included in
the analyses, and considering that the brains of the children and ado-
lescents have not reached its adults size and that they have not yet
reached the average age-at-onset, might have influenced the findings
of the overall effects. In addition, the FDR groups consist of multiple
first-degree relative types (parents, siblings, offspring, co-twins). We
decided not analyze each relative type separately, as our prior study
showed insufficient power to detect group differences between the
different relatives subtypes (de Zwarte, Brouwer, Agartz, et al., 2019).
Importantly, the composition of the SZ-FDRs and BD-FDRs groups
differed. More SZ-FDRs were included, of whom a larger proportion
were siblings, whereas there were more offspring in the BD-FDRs
group. This indicates an overall systematic difference in the way bipo-
lar and schizophrenia families were recruited and highlights that these
are not epidemiologically acquired samples representing the entire
population of relatives. This could confound the differences reported
in the SZ-FDRs and BD-FDRs. Finally, we only analyzed current IQ
and educational attainment as cognitive measures in relation to brain
structure. Little to no information was available in the participating
cohorts on some demographic features, such as parental socioeco-
nomic status (SES), longitudinal cognitive performance (to address
cognitive development over time) and other environmental factors
that are potentially related to brain structure and to risk for schizo-
phrenia and/or bipolar disorder.
5 | CONCLUSIONS
In summary, investigating family members of patients with schizo-
phrenia and bipolar disorder can provide insight into the effect of
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familial risk of these disorders on the brain and cognition. This study
showed differential global cortical thickness and surface area abnor-
malities in SZ-FDRs and BD-FDRs. While present in both relative
groups, cognitive alterations were more pronounced in SZ-FDRs,
adding to the evidence that cognition is more affected in (risk for)
schizophrenia than in (risk for) bipolar disorder. Brain differences in
the relatives were related to cognitive alterations, as expected based
on the well-established positive relationship between intelligence and
brain. However, we found no evidence that the larger ICV in BD-
FDRs was related to IQ, nor were differences in other brain measures
between relatives and controls explained by IQ. This suggests that dif-
ferential brain developmental trajectories underlying predisposition to
schizophrenia or bipolar disorder are only minimally related to IQ. This
study of schizophrenia and bipolar disorder relatives further disentan-
gles the biological underpinnings of both disorders. The resulting find-
ings may also inform the ongoing debate on whether schizophrenia
and bipolar disorder should be conceptualized as different categories
or whether they are part of a continuum of symptoms.
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